Baby Boy, Gumisad .

HRN: 21-57-16  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
07/12/2022
07/19/2022
IVT
15mg
Q24
PSNB
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes